MedTrace Logo

Inhaled Allergen Challenge Methodology: Assessment of a Vibrating Mesh Nebulizer for Allergen Administration

NCT03491358 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-12-10

No results posted yet for this study

Summary

This study will assess the Aerogen Solo® (Solo®) vibrating mesh nebulizer as a potential new device for use in allergen challenge testing.

Conditions

Interventions

DEVICE

Wright jet nebulizer

Roxon Medi-Tech, Montreal, QC, Canada

DEVICE

Aerogen Solo

Aerogen Ltd., Galway, Ireland

Sponsors & Collaborators

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Dr. Don Cockcroft, MD · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-27
Primary Completion
2019-07-24
Completion
2019-07-24

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03491358 on ClinicalTrials.gov